AstraZeneca India Private Limited (AZIPL), the company’s Global Capability Centre (GCC), said today that it has rebranded its Global Technology Centre (GTC) as the Global Innovation and Technology Centre (GITC).
The GTC in Chennai has continuously produced market-leading IT services and capabilities for AstraZeneca’s global company over the last eight years. The center’s portfolio has developed from standard IT services to a critical engine for AstraZeneca’s digital journey and a constant source of technology innovation since its beginnings.
The Chennai center has been successful in increasing efficiency, simplification, technology delivery, and innovation across AstraZeneca’s business, as well as supporting the supply of life-changing medications to patients around the world. The rebranding represents the expansion of the center’s capabilities, as well as its dedication to driving innovation and leading the firm toward a digitally empowered future.
Cindy Hoots, Chief Digital Officer and CIO, AstraZeneca, said, “We live in an era where the possibilities of digital and technology to transform the lives of patients and the healthcare sector, are limitless. Our center in Chennai continues to play a strategic role in our digital transformation, working on Visualization, Data & Analytics, Hyper automation, and XR/VR Capabilities, among other areas. These technologies and innovations play a key role in helping us to advance our science, anticipate patient needs, and work seamlessly across our organization. I am thrilled to see that the work delivered by the team in Chennai is being reflected in our transition from GTC to GITC.”
Siva Padmanabhan, Managing Director, AstraZeneca India Private Limited (AZIPL), said: “The healthcare and life sciences industry is facing unprecedented challenges and opportunities. Over the last few years, we have successfully expanded our skill set and expertise from providing IT services to becoming a pivotal global center driving innovation and transformation. With close to 2,800 highly skilled employees, GITC is now one of the largest technology centers across the Life Sciences industry in the country. The strong collaboration we have been able to build between industry, academia and the government has helped us in our pursuit of enabling smart capabilities at scale across the company’s value chain. Our GITC aims to bring the best of technology, innovation and people to the forefront, to address the ever-evolving healthcare and technology landscape. The rebranding is a powerful acknowledgement of the strategic importance our Chennai center plays in our global operations.”
Both AZIPL centers in Chennai and Bengaluru promote a culture of lifelong learning, which has helped AstraZeneca maintain its status as a Great Place to Work for many years. AstraZeneca is an employer of choice that attracts individuals to offer meaningful, purpose-driven work in a highly inclusive environment because it brings together the greatest brains and cutting-edge resources. Employees at both locations enjoy a happy, physiologically safe, productive, and collaborative work environment with plenty of chances for personal development and advancement.
